Sinovac biotech (Hong Kong) Limited

About Sinovac biotech (Hong Kong) Limited

Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.
SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps.

Certifications
  • HK
  • 2018
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Clinical Research
Contact info
  • Room 1906,19 Floor, 103 Desvoeux Road Wes, Lucky Commercial Building , Hong Kong , Hong Kong, S.A.R., China
Meet us at

CPHI Barcelona 2023

Fira Barcelona Gran Via, Spain
24-26 October 2023

Products from Sinovac biotech (Hong Kong) Limited (3)

  • Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains

    Product Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains

    Launched in 2021.

    Prequalified by the World Health Organization.

    Manufacturing process is result of technology transfer from the WHO and Netherlands-based lntravacc.

    Good safety with zero preservatives and antibiotics.

    Read more on: http://ww...
  • Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive®

    Product Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive®

    • Hepatitis A Vaccine (Human Diploid Cell), Inactivated – Healive® Launched in 2002

    Hepatitis A & Hepatitis B Combined Vaccine – Bilive®
    Launched in 2005

    Healive® is:
    Prequalified by the World Health Organization.
    Provides susta...
  • Influenza Vaccine (Split Virion), lnactivated – Anflu®

    Product Influenza Vaccine (Split Virion), lnactivated – Anflu®

    Influenza Vaccine (Split Virion), lnactivated – Anflu®
    Pandemic Influenza Vaccine, lnactivated, Adjuvanted – Panflu®
    H1N1 Influenza A Vaccine (Split Virion), lnactivated – Panflu.1®
    Influenza Vaccine (Split Virion), lnactivated, Quadrivalent – TetrAnflu®

    Anflu®, preservative-free ...

Sinovac biotech (Hong Kong) Limited Resources (1)

  • Brochure SINOVAC Vaccines leaflets

    Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.

    SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps.